
Sep 1, 2026
Adaptyv raises $40M for AI-run wet labs
Adaptyv, a Swiss biotech firm, has secured $40 million in Series A funding to enhance its automated protein-testing laboratories, aiming to address a potential bottleneck in wet-lab capacity as AI-generated biological designs proliferate.This substantial investment, led by Highland Europe with participation from existing investors such as Ace Ventures, ByFounders, and Y Combinator, positions Adaptyv to scale its operations significantly. The company previously raised $8 million in a Seed round.









